Genetic Analysis AS reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was NOK 3.47 million compared to NOK 2.84 million a year ago. Revenue was NOK 5.67 million compared to NOK 7.62 million a year ago. Net loss was NOK 7.8 million compared to NOK 7.09 million a year ago. Basic loss per share from continuing operations was NOK 0.31. Diluted loss per share from continuing operations was NOK 0.31.
For the full year, sales was NOK 11.16 million compared to NOK 6.8 million a year ago. Revenue was NOK 20.75 million compared to NOK 13.38 million a year ago. Net loss was NOK 28.27 million compared to NOK 29.01 million a year ago. Basic loss per share from continuing operations was NOK 1.13 compared to NOK 1.16 a year ago. Diluted loss per share from continuing operations was NOK 1.13 compared to NOK 1.16 a year ago.